Diabetes and Arteries: Understanding a Major Vascular Risk

Citable definition: Diabetes mellitus is a chronic metabolic disorder that causes sustained elevation of blood glucose (hyperglycemia), leading to progressive structural and functional damage to both large blood vessels (macrovascular disease) and small blood vessels (microvascular disease) — making it one of the leading preventable causes of vascular morbidity and amputation worldwide (Donnelly et al., BMJ, 2000).

Diabetes is often described as a disease of sugar. But for vascular specialists, it is equally — and perhaps more urgently — a disease of blood vessels. Across Europe and North America, diabetes has reached epidemic proportions, and its consequences for the arterial system represent one of the most significant public health challenges of our time.

Understanding how diabetes injures blood vessels, what symptoms it produces, and what can be done to slow or reverse that damage is essential knowledge — not just for clinicians, but for every person living with diabetes or at risk of developing it. This article brings together the best available evidence to give you a clear, complete picture.

What Is Diabetic Vascular Disease?

When blood glucose remains elevated over months and years, it sets in motion a cascade of biological processes that attack the walls of blood vessels from the inside out.

Researchers distinguish two main categories of damage:

• Macrovascular disease — affecting large and medium-sized arteries, including the coronary arteries (supplying the heart), the carotid arteries (supplying the brain), and the peripheral arteries of the legs and feet.
• Microvascular disease — affecting the tiny capillaries that nourish the retina of the eye (diabetic retinopathy), the kidneys (diabetic nephropathy), and the nerves (diabetic neuropathy).

Both forms of vascular injury often coexist and reinforce each other.

At the cellular level, sustained hyperglycemia triggers at least four well-described pathological pathways: the polyol pathway (which diverts glucose into toxic by-products), advanced glycation end-products (AGEs, which stiffen and damage vessel walls), protein kinase C activation (which disrupts normal cell signaling), and the hexosamine pathway. All four ultimately converge on oxidative stress — an excess of damaging free radicals — and chronic inflammation, which erode the delicate inner lining of blood vessels, called the endothelium.

Crucially, this damage begins long before a formal diagnosis of type 2 diabetes. Evidence suggests that even in the pre-diabetic state, endothelial dysfunction is already measurable, which is why vascular risk management must start early.

How Diabetes Affects the Microcirculation

Beyond the large arteries, diabetes exerts a profound effect on the microcirculation — the network of arterioles (tiny arteries), capillaries, and venules that deliver oxygen and nutrients to every tissue in the body.

As Strain and Paldánius discussed in their 2018 review in Cardiovascular Diabetology, microvascular dysfunction in diabetes may represent an independent pathological process with its own mechanisms and clinical consequences, rather than simply a downstream consequence of large-vessel disease (Cardiovascular Diabetology, 2018). Impaired microvascular function reduces tissue perfusion (blood supply), slows wound healing, and amplifies the damage caused by atherosclerosis (the buildup of fatty plaques inside artery walls) in larger vessels.

This is why diabetic foot wounds are so notoriously difficult to heal: the macrovascular supply is compromised by atherosclerosis, while the microvascular reserve that might compensate is itself damaged. The result can be tissue death and, in severe cases, amputation.

Symptoms: What to Watch For

Diabetic vascular disease is insidious — it can be entirely silent for years. When symptoms do appear, they reflect the arteries or organs affected.

Peripheral Artery Disease (PAD)

• Leg pain when walking (intermittent claudication) — a cramping or aching sensation in the calves, thighs, or buttocks that appears during exercise and resolves with rest
• Cold or numb feet
• Slow-healing sores or ulcers on the feet or toes
• Skin color changes (pale or bluish feet)
• In severe cases: critical limb ischemia (critical reduction of blood flow), characterized by rest pain, non-healing wounds, and gangrene

Coronary Artery Disease

• Chest pain or tightness (angina)
• Shortness of breath on exertion
• Note: people with diabetes frequently experience silent myocardial ischemia — heart attacks without the typical chest pain, due to coexisting neuropathy

Cerebrovascular Disease

• Sudden weakness or numbness on one side of the body
• Difficulty speaking
• Vision disturbances — these may represent a TIA (transient ischemic attack), a medical emergency

Microvascular Warning Signs

• Blurred or deteriorating vision (retinopathy)
• Swollen ankles and foamy urine (nephropathy)
• Tingling, burning, or loss of sensation in the feet (neuropathy)

If you experience any of these symptoms, consult your physician or a vascular specialist without delay.

Diagnosis: What to Expect

Early and systematic vascular screening is the cornerstone of diabetic care. Both the European Society for Vascular Surgery (ESVS) and the American Heart Association / American College of Cardiology (AHA/ACC) recommend structured cardiovascular risk assessment for all people with diabetes.

Key diagnostic tools include:

An ABI below 0.9 is generally considered diagnostic of PAD. According to available data, values below 0.5 are associated with severe disease and may indicate critical limb ischemia requiring urgent specialist review; however, readers should note that some guidelines cite a threshold of below 0.4 for critical limb ischemia, and the applicable threshold should be confirmed against the most current ESVS or AHA/ACC PAD guideline documents.

Treatment: From Lifestyle to Surgery

Management of diabetic vascular disease is multi-layered and must be individualized. Our overview of arterial treatments covers many of these approaches in greater depth.

1. Glycemic Control

Keeping HbA1c within target (typically below 53 mmol/mol / 7% for most adults, though targets vary by individual) is the single most important intervention to slow microvascular progression. The UKPDS (UK Prospective Diabetes Study) demonstrated that each 1% reduction in HbA1c is associated with a 37% reduction in microvascular complications, according to available data (Stratton IM et al., BMJ, 2000;321:405–412).

2. Cardiovascular Risk Factor Management

• Statins (cholesterol-lowering medications): recommended for many adults with diabetes, particularly those over 40 and younger patients with additional risk factors — specific eligibility criteria vary between guidelines (e.g., ADA Standards of Care, ESC/EASD guidelines, AHA/ACC cholesterol guidelines) and should be confirmed with your treating physician
• Antihypertensive therapy: target blood pressure below 130/80 mmHg in most guidelines
• Antiplatelet therapy (e.g., aspirin or clopidogrel): recommended in established cardiovascular disease

3. Supervised Exercise

Structured walking programs remain one of the most evidence-based treatments for intermittent claudication. Supervised exercise therapy has been shown to improve walking distance and quality of life, and is recommended as first-line therapy by both European and American guidelines before considering revascularization.

4. Wound Care and Podiatry

For diabetic foot disease, a multidisciplinary team approach — including vascular surgeons, podiatrists, diabetologists, and infectious disease specialists — is the international standard of care.

5. Endovascular and Surgical Revascularization

When conservative measures fail and limb viability is threatened, revascularization may be necessary:

Endovascular approaches (including EVAR — endovascular aneurysm repair — for aortic disease) have expanded dramatically in recent years and are increasingly the first choice in many European centers, reflecting growing technical expertise and improved device technology.

Prevention: Protecting Your Arteries Every Day

The good news is that a substantial proportion of diabetic vascular complications are preventable. Evidence-based daily habits include:

• Achieve and maintain glycemic targets — work with your diabetes care team to optimize medication and lifestyle
• Follow a Mediterranean-style diet — rich in vegetables, legumes, whole grains, olive oil, and fish; associated with reduced cardiovascular events in multiple large trials
• Exercise regularly — at least 150 minutes of moderate aerobic activity per week (AHA recommendation)
• Stop smoking — smoking is the single most powerful modifiable risk factor for PAD; cessation dramatically reduces progression
• Inspect your feet daily — check for cuts, blisters, or color changes; wear well-fitting shoes; never walk barefoot if you have neuropathy
• Attend all scheduled screening appointments — annual foot checks, eye examinations, kidney function tests, and cardiovascular review
• Control blood pressure and cholesterol — medication adherence is critical

For more evidence-based prevention strategies, visit our prevention section.

When to See a Doctor

Seek urgent medical attention if you experience:

• A new, non-healing wound or ulcer on your foot or leg
• Sudden onset of severe leg pain at rest, especially at night
• A cold, pale, or blue foot that has changed suddenly
• Chest pain, shortness of breath, or palpitations
• Sudden weakness, speech difficulty, or vision loss (call emergency services immediately — this may be a stroke)

Schedule a routine specialist review if you notice:

• Leg cramps or fatigue when walking that resolves with rest
• Gradual loss of sensation in the feet
• Persistent swelling in one or both legs
• Any change in the appearance of your feet or toes

Early detection saves limbs — and lives. Do not wait for symptoms to worsen before consulting your physician or a vascular specialist.

Also available in French

Sources

1. Rask-Madsen C, King GL. Vascular complications of diabetes: mechanisms of injury and protective factors. Cell Metabolism. 2013;17(1):20–33. DOI: 10.1016/j.cmet.2012.11.012 | PMID: 23312281 (Note: abstract pending verification for publication.)

2. Strain WD, Paldánius PM. Diabetes, cardiovascular disease and the microcirculation. Cardiovascular Diabetology. 2018;17(1):57. DOI: 10.1186/s12933-018-0703-2 | PMID: 29720198 (Note: abstract pending verification for publication.)

3. Donnelly R, Emslie-Smith AM, Gardner ID, Morris AD. Vascular complications of diabetes. BMJ. 2000;320(7241):1062–1066. DOI: 10.1136/bmj.320.7241.1062 | PMID: 10764371 (Note: abstract pending verification for publication.)

4. Stratton IM, Adler AI, Neil HAW, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405–412. DOI: 10.1136/bmj.321.7258.405 (Note: abstract pending verification for publication.)

Medical Disclaimer: This article is produced by the Petit Veinard Editorial Board for informational and educational purposes only. It does not constitute medical advice, diagnosis, or a treatment recommendation. Vascular and metabolic conditions vary significantly between individuals. Always consult a qualified physician or vascular specialist before making any decisions about your health or treatment. In the event of a medical emergency, contact your local emergency services immediately.